The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.

by Sandra Gordon

Facts and Stats

New report highlights decades of progress, as well as a persisting disparity.

by Thomas Celona

Early findings on therapeutic vaccines suggest they can delay or stop cancer from returning after tumors are surgically removed.

by Kendall K. Morgan

Forward Look

Medical oncologist Michael B. Streiff discusses new guidelines to reduce the risk of life-threatening blood clots.

by Ashley P. Taylor

Forward Look

Almost all childhood cancer survivors will develop significant health problems related to their treatment by age 45.

by Suzanne McBride

Forward Look

Some people with muscle-invasive cancer can forgo bladder removal surgery.

by Darcy Lewis

From the Editor-in-Chief

Researchers search for reasons for the growing number of cases in people under 50.

by William G. Nelson, MD, PhD

The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?

by Sandra Gordon

Studies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce benefits from these tactics.

by Cancer Research Catalyst

SABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.

by Marci A. Landsmann